Work Here?
Overview
Rezo Therapeutics maps disease networks to develop precision medicines. Its SSD platform combines proteomics, genetics, structural biology, chemistry, and bioinformatics to build maps of molecular disease networks and identify druggable targets, with a focus on solid tumors. Unlike single-target approaches, it maps whole networks to reveal tumor-specific vulnerabilities and guide therapy development, supported by UCSF QBI origins. The goal is to translate network biology into a pipeline of targeted therapeutics through internal programs and strategic partnerships.
About Rezo Therapeutics
Industries
Data & Analytics
AI & Machine Learning
Biotechnology
Healthcare
Company Size
11-50
Company Stage
Series A
Total Funding
$78M
Headquarters
San Francisco, California
Founded
2021
People at Rezo Therapeutics
People at Rezo Therapeutics who can refer or advise you
Simplify's Take
What believers are saying
- Derek Hicks, appointed CEO in August 2025, brings 25 years of biopharma leadership from Pfizer and Spark Therapeutics.
- Cristiana Guiducci, PhD, as CSO, adds 19 years of drug discovery expertise to strengthen solid tumor oncology pipeline.
- Rezo achieved a 90% reduction in Google Cloud compute costs while advancing AI-powered drug discovery efficiently.
What critics are saying
- Clarimedix and Recursion outperform Rezo's SSD in target discovery accuracy for solid tumors within 12–18 months.
- Failure of Rezo's lead solid tumor candidate entering Phase 1 by Q2 2027 could cause catastrophic company collapse.
- NVIDIA's in silico protein prediction reliance creates a bottleneck if access is restricted or fees exceed $78M runway.
What makes Rezo Therapeutics unique
- Rezo's SSD platform integrates proteomics, genetics, and bioinformatics to map molecular disease networks.
- The company leverages UCSF QBI technology to identify tumor-specific vulnerabilities missed by traditional methods.
- Rezo turns undruggable protein–protein interactions into drug targets using Google Cloud-powered network AI models.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$78M
Above
Industry Average
Funded Over
1 Rounds
SV Angel
Andreessen HorowitzIndustry standards
Benefits
Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
Commuter Benefits
Health Savings Account/Flexible Spending Account
Dependent care Flexible Spending Account
Parental Leave
Flexible Work Hours
Paid Holidays
Growth & Insights
6 month growth
↑ 0%1 year growth
↓ -2%2 year growth
↑ 2%Rezo Therapeutics is Hiring for 4 Jobs on Simplify!
Find jobs on Simplify and start your career today
About Rezo Therapeutics
Industries
Data & Analytics
AI & Machine Learning
Biotechnology
Healthcare
Company Size
11-50
Company Stage
Series A
Total Funding
$78M
Headquarters
San Francisco, California
Founded
2021
Rezo Therapeutics is Hiring for 4 Jobs on Simplify!
Find jobs on Simplify and start your career today